DMAC - DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2021 Results - Earnings Call Transcript

DiaMedica Therapeutics Inc. (DMAC) Q1 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Rick Pauls - President & Chief Executive Officer Scott Kellen - Chief Financial Officer Harry Alcorn - Chief Medical Officer Conference Call Participants Alexander Nowak - Craig-Hallum Capital Group Etzer Darout - Guggenheim Partners Francois Brisebois - Oppenheimer & Co. Inc. Thomas Flaten - Lake Street Capital Markets, LLC Elemer Piros - ROTH Capital Partners Jason McCarthy - Maxim Group, LLC Presentation Operator Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2021 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section. Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risk and uncertainties that could

For further details see:

DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2021 Results - Earnings Call Transcript